Please assess the completion status of the following clinical trial:

Trial Title: Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age \< 18 years~* American Society of Anesthesiologists risk I-II~* patients undergoing to Gastroscopy or Colonoscopy~Exclusion Criteria:~* significant systemic disease~* allergic reactions to any of study drugs~* chronic use of opioids or psychiatric disorders~* pregnancy~* Mallampati score \> 2~* age \< 18 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- propofol group (Type: EXPERIMENTAL): 70 patients (35 upper endoscopy - 35 colonoscopy)
- midazolam group (Type: ACTIVE_COMPARATOR): 70 patients (35 upper endoscopy - 35 colonoscopy)

Based on this trial design, predict the completion outcome and termination type (if applicable).